Varicella Virus Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Video
• Alerts
• Clinical Trials

An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children
Condition:   InfluenzaInterventions:   Biological: Influenza vaccine GSK2321138A;   Biological: Havrix Junior;   Biological: Prevenar 13;   Biological: Varivax/ProVarivax;   Biological: VarilrixSponsor:   GlaxoSmithKlineCompleted - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2011 Category: Research Source Type: clinical trials

An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children
Condition:   InfluenzaInterventions:   Biological: Influenza vaccine GSK2321138A;   Biological: Havrix Junior;   Biological: Prevenar 13;   Biological: Varivax/ProVarivax;   Biological: VarilrixSponsor:   GlaxoSmithKlineCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2011 Category: Research Source Type: clinical trials

An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children
Condition:   InfluenzaInterventions:   Biological: Influenza vaccine GSK2321138A;   Biological: Havrix Junior;   Biological: Prevenar 13;   Biological: Varivax/ProVarivax;   Biological: VarilrixSponsor:   GlaxoSmithKlineCompleted - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2011 Category: Research Source Type: clinical trials

An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children
Condition:   InfluenzaInterventions:   Biological: Influenza vaccine GSK2321138A;   Biological: Havrix Junior;   Biological: Prevenar 13;   Biological: Varivax/ProVarivax;   Biological: VarilrixSponsor:   GlaxoSmithKlineCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2011 Category: Research Source Type: clinical trials

An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children
Condition:   InfluenzaInterventions:   Biological: Influenza vaccine GSK2321138A;   Biological: Havrix Junior;   Biological: Prevenar 13;   Biological: Varivax/ProVarivax;   Biological: VarilrixSponsor:   GlaxoSmithKlineCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2011 Category: Research Source Type: clinical trials

A Study to Evaluate Long-term Impact of VARIVAX Among Children and Adolescents (V210-036)(COMPLETED)
Conditions:   Varicella;   Herpes ZosterIntervention:   Sponsors:   Merck Sharp & Dohme Corp.;   Kaiser PermanenteCompleted - verified February 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2010 Category: Research Source Type: clinical trials

A Study to Evaluate Long-term Impact of VARIVAX Among Children and Adolescents (V210-036)(COMPLETED)
Conditions:   Varicella;   Herpes ZosterIntervention:   Sponsors:   Merck Sharp & Dohme Corp.;   Kaiser PermanenteCompleted - verified August 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2010 Category: Research Source Type: clinical trials